GLYCOMIMETICS, INC.
Patent Owner
Stats
- 29 US PATENTS IN FORCE
- 3 US APPLICATIONS PENDING
- Mar 08, 2018 most recent publication
Details
- 29 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,130 Total Citation Count
- May 05, 1994 Earliest Filing
- 22 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0296,566 METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING MUCOSITISSep 29, 14Oct 19, 17[A61K, C07H]
2016/0333,043 E-Selectin Antagonists Modified By Macrocycle Formation to the GalactoseJan 15, 15Nov 17, 16[C07H]
2016/0184,339 Compounds, Compositions and Methods Using E-Selectin Antagonists for Mobilization of Hematopoietic CellsDec 05, 13Jun 30, 16[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9867841 Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cellsDec 05, 13Jan 16, 18[A61K]
9796745 E-selectin antagonist compounds, compositions, and methods of useJun 26, 15Oct 24, 17[A61K, C07H]
9534009 Pan-selectin inhibitor with enhanced pharmacokinetic activityOct 28, 14Jan 03, 17[A61K, C07H]
9109002 E-selectin antagonist compounds, compositions, and methods of useDec 21, 12Aug 18, 15[C07H, A61K]
8895510 Pan-selectin inhibitor with enhanced pharmacokinetic activityApr 06, 09Nov 25, 14[A61K, C07H, A61P]
8530448 Compounds and methods for inhibiting selectin-mediated functionApr 02, 10Sep 10, 13[A61K, C07H]
8518896 Treatment of cancers of the blood using selected glycomimetic compoundsJun 10, 09Aug 27, 13[A61K, A61P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0331,775 E-SELECTIN INHIBITION WORKS IN COMBINATION WITH LOW-MOLECULAR WEIGHT HEPARIN TO DECREASE VENOUS THROMBOSIS AND BLEEDING RISKAbandonedMay 13, 16Nov 17, 16[A61K]
2014/0073,594 GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIVAbandonedNov 15, 13Mar 13, 14[C07H]
2013/0184,229 HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTINS AND CXCR4 CHEMOKINE RECEPTORSAbandonedMar 05, 13Jul 18, 13[C07H]
2012/0329,755 GLYCOMIMETIC INHIBITORS OF THE PA-IL LECTIN, PA-IIL LECTIN OR BOTH THE LECTINS FROM PSEUDOMONASAbandonedAug 03, 12Dec 27, 12[A61K, C08B, A61P]
2012/0202,762 METHODS OF USE OF GLYCOMIMETICS WITH REPLACEMENTS FOR HEXOSES AND N-ACETYL HEXOSAMINESAbandonedSep 02, 11Aug 09, 12[A61K, A61P]
2011/0257,380 GLYCOMIMETIC REPLACEMENTS FOR HEXOSES AND N-ACETYL HEXOSAMINESAbandonedApr 25, 11Oct 20, 11[C07H]
2011/0251,148 GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIVAbandonedApr 06, 11Oct 13, 11[A61K, C07H, A61P]
2011/0027,180 DETECTION AND TREATMENT OF PROSTATE CANCERAbandonedApr 13, 10Feb 03, 11[A61K, G01N, A61P]
2009/0176,717 GALACTOSIDES AND THIODIGALACTOSIDES AS INHIBITORS OF PA-IL LECTIN FROM PSEUDOMONASAbandonedMay 30, 07Jul 09, 09[A61K, C12N, G01N]
2009/0036,386 Heterobifunctional compounds for selectin inhibitionAbandonedMay 24, 06Feb 05, 09[A61K, C07H]
2005/0187,171 Glycomimetic antagonists for both E-and P-selectinsAbandonedNov 18, 04Aug 25, 05[A61K]
2004/0219,158 Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteriaAbandonedDec 19, 03Nov 04, 04[A61K]
2004/0096,396 Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesisAbandonedJun 19, 03May 20, 04[A61K]
6465434 Methods and compositions for the inhibition of cancer metastasis mediated by endothelial adhesion moleculesExpiredNov 23, 99Oct 15, 02[A01N]
6281202 Pharmaceutical compositions for treatment of EGF receptor associated cancersExpiredAug 23, 99Aug 28, 01[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.